JB Capital’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
JB Capital's ELV Position: Q3 2026 in Review
JB Capital reduced its Elevance Health (ELV) stake by 85% in Q3 2026, selling an estimated $4.27M and leaving 1,908 shares worth $742K. The position accounts for 0.03% of the portfolio, ranked #156.
JB Capital first reported a position in ELV in Q3 2021 and has held it in 21 quarters since. The position peaked at $4.87M in Q2 2026. 399 funds tracked by Wall St. Rank hold ELV as of Q3 2026.
- JB Capital held 1,908 shares of Elevance Health worth $742K as of Q3 2026.
- JB Capital sold 10,690 Elevance Health shares in Q3 2026, an estimated $4.27M.
- Elevance Health made up 0.03% of JB Capital's portfolio in Q3 2026, its #156 holding.
- JB Capital first reported a position in Elevance Health in Q3 2021 and has held it in 21 quarters since.
- JB Capital's Elevance Health position peaked at $4.87M in Q2 2026.
- 399 funds tracked by Wall St. Rank held Elevance Health as of Q3 2026.
Based on JB Capital's 13F filing for Q3 2026, filed 19 Oct 2026.